SynthesisHaematologica2014

Measurement of adherence to BCR-ABL inhibitor therapy in chronic myeloid leukemia: current situation and future challenges.

Lucien Noens et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.